Tsung-Wei Chen Selected Research

Methyltransferases

2/2020

Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsung-Wei Chen Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 01/2017
10	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2018
10	Rectal Neoplasms (Rectal Cancer) 07/2023 - 11/2016
8	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 07/2023
2	Bites and Stings (Sting) 05/2024 - 01/2022
2	Adenocarcinoma 02/2024 - 07/2022
2	Colonic Neoplasms (Colon Cancer) 01/2024 - 07/2023
2	Lymphatic Metastasis 11/2023 - 02/2019
2	Carcinoma (Carcinomatosis) 11/2023 - 12/2020
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2023 - 10/2021
2	Infections 01/2019 - 01/2019
1	Ulcerative Colitis 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Hyperkalemia 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Uremia 01/2021
1	Hemorrhage 01/2020
1	Tuberculosis (Tuberculoses) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Follicular Adenocarcinoma 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2018
3	HMGB1 Protein (HMG1)IBA 11/2023 - 01/2018
3	B7-H1 AntigenIBA 01/2022 - 10/2018
3	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	LigandsIBA 12/2020 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 02/2020
2	Interferon Type IIBA 05/2024 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 01/2024 - 07/2023
2	Pattern Recognition ReceptorsIBA 07/2023 - 10/2021
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2021 - 01/2021
2	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 01/2021 - 01/2020
1	RNA (Ribonucleic Acid)IBA 05/2024
1	Caspase 8 (Caspase-8)IBA 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	Indicators and Reagents (Reagents)IBA 11/2023
1	ParaffinIBA 07/2023
1	Adenosine (Adenocard)FDA LinkGeneric 07/2023
1	Formaldehyde (Formol)FDA Link 07/2023
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021
1	MethyltransferasesIBA 02/2020
1	Decitabine FDA Link 02/2020
1	GoldIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Calcibiotic Root Canal SealerIBA 01/2019
1	Dynamins (Dynamin)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	RacivirIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Thyroid Nuclear Factor 1IBA 01/2017
1	IodineIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Thyroglobulin FDA Link 01/2017
1	Capecitabine (Xeloda)FDA Link 11/2016

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 02/2024 - 11/2016
7	Neoadjuvant Therapy 10/2021 - 01/2018
6	Adjuvant Chemotherapy 01/2024 - 01/2021
5	Radiotherapy 05/2024 - 04/2019
4	Immunotherapy 01/2024 - 02/2020
4	Chemoradiotherapy 10/2021 - 11/2016
3	Therapeutics 01/2022 - 01/2017
1	Combined Modality Therapy 02/2024
1	Transplantation 01/2021
1	Precision Medicine 05/2020
1	Thyroidectomy 01/2017